Noninfectious pulmonary complications of infection with the human immunodeficiency virus (Q38747039)

6 September 2017

1 reference

title

Noninfectious pulmonary complications of infection with the human immunodeficiency virus (English)

1 reference

6 September 2017

White DA

1

1 reference

6 September 2017

Matthay RA

series ordinal

2

1 reference

6 September 2017

publication date

1 December 1989

1 reference

The American Review of Respiratory Disease

6 September 2017

published in

1 reference

6 September 2017

volume

140

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

1763-1787

1 reference

Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Kaposi's sarcoma in Uganda: A clinico‐pathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Association of Kaposi's sarcoma with second primary malignancies possible etiopathogenic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Kaposi's sarcoma: relationship with hematologic, lymphoid, and thymic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary Kaposi's sarcoma in two recipients of renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Kaposi's sarcoma in recipients of renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Molecular Characterization of Human T-Cell Leukemia (Lymphotropic) Virus Type III in the Acquired Immune Deficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Antibody patterns to herpesviruses in Kaposi's sarcoma. II. Serological association of american Kaposi's sarcoma with cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary manifestations of Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Kaposi's sarcoma of the lung: radiography and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Rapidly fatal lymphangioma-like Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary Kaposi's sarcoma: clinical findings and results of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Acquired immunodeficiency syndrome: Ga-67 citrate imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Lymphomas in men at high risk for acquired immune deficiency syndrome (AIDS). A study of 21 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

AIDS-associated non-Hodgkin's lymphoma in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pathogenesis of Burkitt lymphoma: expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Retrovirus and malignant lymphoma in homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Non-Hodgkin's lymphoma in a population with or at risk for acquired immunodeficiency syndrome: indications for intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Primary pulmonary lymphoma in a patient with the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Autopsy findings in AIDS-related lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Lymphadenopathy in an inner-city population consisting principally of intravenous drug abusers with suspected acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary manifestations of AIDS: review of 106 episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Concomitant infection with HTLV-I and HTLV-III in a patient with T8 lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Lymphocytic interstitial pneumonitis. Review of 13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Diffuse lymphoid interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Human immunodeficiency virus recovery from bronchoalveolar lavage fluid in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Recovery of human immunodeficiency virus and detection of p24 antigen in bronchoalveolar lavage fluid from adult patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary disease in children with acquired immune deficiency syndrome and AIDS-related complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Acquired immunodeficiency syndrome in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Polyclonal polymorphic B-cell lymphoproliferative disorder with prominent pulmonary involvement in children with acquired immune deficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Extensive T8-positive lymphocytic visceral infiltration in a homosexual man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Lymphocytic interstitial pneumonia in patients at risk for the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Pulmonary cell populations in the immunosuppressed patient. Bronchoalveolar lavage findings during episodes of pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Human immunodeficiency virus-related lymphocytic alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

AIDS virus-specific cytotoxic T lymphocytes in lung disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Long-term follow-up of drug abusers with intravenous talcosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Talcosis Presenting as Pulmonary Infiltrates in an HIV-Positive Heroin Addict

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Steroid-induced Kaposi's sarcoma in a patient with pre-AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Fulminant Kaposi's sarcoma complicating long-term corticosteroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

21 January 2018

Another look at ARDS.

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

Abnormal Airway Function in Individuals with the Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FAJRCCM%2F140.6.1763

10.1164/AJRCCM/140.6.1763

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference